226 related articles for article (PubMed ID: 17064803)
1. A prospective phase II study of adjuvant postoperative radiation therapy following nodal surgery in malignant melanoma-Trans Tasman Radiation Oncology Group (TROG) Study 96.06.
Burmeister BH; Mark Smithers B; Burmeister E; Baumann K; Davis S; Krawitz H; Johnson C; Spry N;
Radiother Oncol; 2006 Nov; 81(2):136-42. PubMed ID: 17064803
[TBL] [Abstract][Full Text] [Related]
2. Combined-modality therapy for patients with regional nodal metastases from melanoma.
Ballo MT; Ross MI; Cormier JN; Myers JN; Lee JE; Gershenwald JE; Hwu P; Zagars GK
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):106-13. PubMed ID: 16182463
[TBL] [Abstract][Full Text] [Related]
3. The benefits of adjuvant radiation therapy after therapeutic lymphadenectomy for clinically advanced, high-risk, lymph node-metastatic melanoma.
Agrawal S; Kane JM; Guadagnolo BA; Kraybill WG; Ballo MT
Cancer; 2009 Dec; 115(24):5836-44. PubMed ID: 19701906
[TBL] [Abstract][Full Text] [Related]
4. A critical assessment of adjuvant radiotherapy for inguinal lymph node metastases from melanoma.
Ballo MT; Zagars GK; Gershenwald JE; Lee JE; Mansfield PF; Kim KB; Camacho LH; Hwu P; Ross MI
Ann Surg Oncol; 2004 Dec; 11(12):1079-84. PubMed ID: 15576833
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant postoperative radiotherapy to the cervical lymph nodes in cutaneous melanoma: is there any benefit for high-risk patients?
Moncrieff MD; Martin R; O'Brien CJ; Shannon KF; Clark JR; Gao K; McCarthy WM; Thompson JF
Ann Surg Oncol; 2008 Nov; 15(11):3022-7. PubMed ID: 18958539
[TBL] [Abstract][Full Text] [Related]
6. Melanoma metastatic to cervical lymph nodes: Can radiotherapy replace formal dissection after local excision of nodal disease?
Ballo MT; Garden AS; Myers JN; Lee JE; Diaz EM; Sturgis EM; Morrison WH; Gershenwald JE; Ross MI; Weber RS; Ang KK
Head Neck; 2005 Aug; 27(8):718-21. PubMed ID: 15952196
[TBL] [Abstract][Full Text] [Related]
7. Role of postoperative irradiation for patients with bilateral cervical nodal metastases from cutaneous melanoma: a critical assessment.
Guadagnolo BA; Myers JN; Zagars GK
Head Neck; 2010 Jun; 32(6):708-13. PubMed ID: 19787786
[TBL] [Abstract][Full Text] [Related]
8. Does chemotherapy improve survival in high-risk stage I and II Merkel cell carcinoma of the skin?
Poulsen MG; Rischin D; Porter I; Walpole E; Harvey J; Hamilton C; Keller J; Tripcony L
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):114-9. PubMed ID: 16125873
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial.
Burmeister BH; Henderson MA; Ainslie J; Fisher R; Di Iulio J; Smithers BM; Hong A; Shannon K; Scolyer RA; Carruthers S; Coventry BJ; Babington S; Duprat J; Hoekstra HJ; Thompson JF
Lancet Oncol; 2012 Jun; 13(6):589-97. PubMed ID: 22575589
[TBL] [Abstract][Full Text] [Related]
10. Radiation therapy following lymph node dissection in melanoma patients: treatment, outcome and complications.
Bastiaannet E; Beukema JC; Hoekstra HJ
Cancer Treat Rev; 2005 Feb; 31(1):18-26. PubMed ID: 15707701
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant radiotherapy for cutaneous melanoma: comparing hypofractionation to conventional fractionation.
Chang DT; Amdur RJ; Morris CG; Mendenhall WM
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1051-5. PubMed ID: 16973303
[TBL] [Abstract][Full Text] [Related]
12. An innovative approach for locally advanced stage III cutaneous melanoma: radiotherapy, followed by nodal dissection.
Foote M; Burmeister B; Dwyer P; Burmeister E; Lambie D; Allan C; Barbour A; Bayley G; Pullar A; Meakin J; Thomas J; Smithers M
Melanoma Res; 2012 Jun; 22(3):257-62. PubMed ID: 22547205
[TBL] [Abstract][Full Text] [Related]
13. Local control of primary Merkel cell carcinoma: review of 45 cases treated with Mohs micrographic surgery with and without adjuvant radiation.
Boyer JD; Zitelli JA; Brodland DG; D'Angelo G
J Am Acad Dermatol; 2002 Dec; 47(6):885-92. PubMed ID: 12451374
[TBL] [Abstract][Full Text] [Related]
14. Involved-nodal radiation therapy as a component of combination therapy for limited-stage Hodgkin's lymphoma: a question of field size.
Campbell BA; Voss N; Pickles T; Morris J; Gascoyne RD; Savage KJ; Connors JM
J Clin Oncol; 2008 Nov; 26(32):5170-4. PubMed ID: 18838714
[TBL] [Abstract][Full Text] [Related]
15. Elective radiation therapy for high-risk malignant melanomas.
Cooper JS; Chang WS; Oratz R; Shapiro RL; Roses DF
Cancer J; 2001; 7(6):498-502. PubMed ID: 11769862
[TBL] [Abstract][Full Text] [Related]
16. Desmoplastic melanoma: the role of radiotherapy in improving local control.
Foote MC; Burmeister B; Burmeister E; Bayley G; Smithers BM
ANZ J Surg; 2008 Apr; 78(4):273-6. PubMed ID: 18366400
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant therapy for melanoma.
Sondak VK
Cancer J; 2001; 7 Suppl 1():S24-7. PubMed ID: 11504282
[TBL] [Abstract][Full Text] [Related]
18. Regional control of melanoma neck node metastasis after selective neck dissection with or without adjuvant radiotherapy.
Hamming-Vrieze O; Balm AJ; Heemsbergen WD; Hooft van Huysduynen T; Rasch CR
Arch Otolaryngol Head Neck Surg; 2009 Aug; 135(8):795-800. PubMed ID: 19687401
[TBL] [Abstract][Full Text] [Related]
19. [Adjuvant chemotherapy as a component of complex treatment for skin melanoma].
Kudriavtsev DV; Kudriavtseva GT; Mardynskiĭ IuS
Vopr Onkol; 2008; 54(2):170-7. PubMed ID: 18522165
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial.
Henderson MA; Burmeister BH; Ainslie J; Fisher R; Di Iulio J; Smithers BM; Hong A; Shannon K; Scolyer RA; Carruthers S; Coventry BJ; Babington S; Duprat J; Hoekstra HJ; Thompson JF
Lancet Oncol; 2015 Sep; 16(9):1049-1060. PubMed ID: 26206146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
